Centessa Pharmaceuticals (CNTA) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $680000.0.
- Centessa Pharmaceuticals' Accumulated Depreciation & Amortization fell 449.44% to $680000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $680000.0, marking a year-over-year decrease of 449.44%. This contributed to the annual value of $942000.0 for FY2024, which is 1629.63% up from last year.
- As of Q3 2025, Centessa Pharmaceuticals' Accumulated Depreciation & Amortization stood at $680000.0, which was down 449.44% from $443000.0 recorded in Q2 2025.
- Over the past 5 years, Centessa Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $942000.0 during Q4 2024, and registered a low of $28000.0 during Q1 2022.
- For the 4-year period, Centessa Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $387533.3, with its median value being $326000.0 (2023).
- Per our database at Business Quant, Centessa Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 51832.06% in 2023 and then tumbled by 958.33% in 2025.
- Over the past 4 years, Centessa Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $131000.0 in 2022, then skyrocketed by 518.32% to $810000.0 in 2023, then grew by 16.3% to $942000.0 in 2024, then fell by 27.81% to $680000.0 in 2025.
- Its Accumulated Depreciation & Amortization was $680000.0 in Q3 2025, compared to $443000.0 in Q2 2025 and $217000.0 in Q1 2025.